However, there have been calls for extra checks on the science before it goes ahead in the UK.

Prof Robin Lovell-Badge, one of the researchers who reviewed the evidence, said the moment had come.

“We”re not going to learn much more now unless you try it out for real basically – it”s at that stage,” he said.

“There”s no reason why it shouldn”t go ahead now, but do it cautiously on selected patients where the risk of having a badly affected child is very high.”

The structure of a cell

Nucleus: where the majority of our DNA is held – this determines how we look and our personality

Mitochondria: often described as the cell”s factories, these create the energy to make the cell function

Cytoplasm: the jelly-like substance that contains the nucleus and mitochondria

However, the technique can still lead to some defective mitochondria ending up in the resulting embryo.

A study, published in Nature, suggests those defective mitochondria could still take over in one in eight babies and cause disease.

Researchers at Oregon Health and Science Unit created embryos from four women who had children with mitochondrial disease.

Samples of those embryonic cells were then grown in the laboratory.

Prof Paula Amato, who published her findings in the journal Nature, said: “Some embryonic stem cell lines did revert back to the mutant mitochondrial DNA.”

The scientific review team has recommended extra checks during pregnancy to ensure the baby is healthy.

Prof Lovell-Badge said: “It”s likely to be something we have to worry about if the experiments that have been done on embryonic stem cells are representative of embryos that were re-implanted.

“That”s why we recommend a pre-natal diagnosis method to check whether reversion is occurring in the developing foetus.”

A team in Newcastle has pioneered research in the field and is likely to be the first to be given a licence to make three-person babies.

Prof Doug Turnbull, from Newcastle University, said: “This is obviously great news, and I agree with the report conclusions.

“I think the report highlights the very careful way in which the UK has proceeded with this new IVF technique and hope the HFEA [Human Fertilisation and Embryology Authority] approve this at their meeting in December.”

Commenting on the report, Prof Bert Smeets, from Maastricht University, said: “It is historic that the independent science review panel concludes that it is appropriate to offer mitochondrial donation techniques as clinical risk reduction treatment for carefully selected patients.”